Incyte
Rose-Ann Blenman-Abange, Ph.D., CPM, is a highly experienced professional in clinical development operations and project management, currently serving as Senior Director, Business Partner for Clinical Development Operations & PPM at Incyte since April 2025. With a background that includes advisory and investment roles at RoseCeutics LLC since 2011 and significant positions at Johnson & Johnson and Merck, Rose-Ann specializes in R&D digital transformation, operational excellence, and strategic management within the life sciences sector. Educational qualifications include a Ph.D. in Biomedical Engineering from the Mayo Clinic Graduate School of Biomedical Sciences, a B.S. in Physics from Dillard University, and secondary education at Queen's College Barbados.
This person is not in any teams
This person is not in any offices
Incyte
22 followers
Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs.